Feature | December 23, 2013

WHO Study: Atrial Fibrillation is a Growing Global Health Concern

December 23, 2013 — Atrial fibrillation (AF), long considered the most common condition leading to an irregular heartbeat, is a growing and serious global health problem, according to the first study ever to estimate the condition’s worldwide prevalence, death rates and societal costs.
The World Health Organization (WHO) data analysis, led by Sumeet Chugh, M.D., associate director, Cedars-Sinai Heart Institute, shows 33.5 million people worldwide — or 0.5 percent of the world’s population — have the condition. Funded partly by the Bill & Melinda Gates Foundation and the Cedars-Sinai Heart Institute, the analysis was conducted with the assistance of the University of Washington University’s Institute for Health Metrics and Evaluation.
The study, believed to be the first to determine the number of people globally with AF, is published online in the peer reviewed medical journal Circulation and is scheduled to be published in the Feb. 25 print edition of the journal.
“Atrial fibrillation has a huge cost in every sense of the word,” said Chugh. “It can lead to stroke, hospitalization, as well as lost productivity. Our findings indicate that atrial fibrillation is on the rise around the world and it’s a huge public health burden.”
During the analysis, Chugh and a team of researchers systematically analyzed data from selected population-based research studies — from among 1,784 published medical research studies on AF — to estimate global and regional prevalence, incidence and mortality related to this condition.
“Finding out the scope of the problem is step No. 1,” said Chugh. “Our hope is that we can develop a sustainable global plan to manage atrial fibrillation and find new and effective ways of preventing this condition.”
Among the study’s findings:
  • In 1990, an estimated 570 of 100,000 men had AF. In 2010, the prevalence rate for men was 596 of 100,000.
  • For females, an estimated 360 of 100,000 women had AF in 1990. In 2010, that rose to 373 of 100,000.
  • In 1990, the number of new cases of AF in men was estimated at 61 per 100,000. In 2010, the number of men with new cases of AF rose to 78 per 100,000.
  • The number of new cases of AF in women was 43 per 100,000 in 1990. In 2010, the number of new cases in women was 60 per 100,000.
  • Although deaths linked to AF are rising around the world, more women with AF are dying in developing countries. In the United States, deaths linked to AF now are comparable between the sexes.
“A lot more research is needed to fully understand this continuing worldwide increase,” said Chugh. “Although the chance of developing atrial fibrillation does increase with age, these findings are not entirely explained by the aging world population. Several other factors have been suggested and need to be better evaluated, from obesity and hypertension to air pollution.”
For more information: cedars-sinai.edu, circ.ahajournals.org

Related Content

coherex Wave Crest LAA Occluder

Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.

News | November 24, 2015
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device
News | Heart Valve Repair| November 23, 2015
NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its catheter-guided, mitral-valved...
Boston Scientific, Watchman FLX, LAA closure device, CE mark, first European implants

Image courtesy of Boston Scientific

News | Left Atrial Appendage (LAA) Occluders| November 20, 2015
Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure (LAAC) device
iRhythm Technologies, ZIO continuous cardiac monitoring service, myZIO app, irregular heartbeat symptoms, reporting

Image courtesy of iRhythm Technologies

Technology | ECG Monitoring Services| November 19, 2015
iRhythm Technologies Inc. announced the launch of new patient engagement tools to enhance the diagnosis of cardiac...
wearable Holter monitors, iRhythm, ziopatch, zio patch

iRhythm Technologies Zio Patch was among the first of a new generation of simplified, wearable Holter monitors designed to increase ease of use and patient compliance to increase detection of arrhythmias that may lead to stroke.

Feature | Holter Monitoring Systems| November 16, 2015 | Judy Lenane, RN, MHA
One-third of ischemic strokes are classified as cryptogenic.
protein reprogramming, Stem Cells Translational Medicine, cardiac progenitor cells, CPCs, regenerative therapies
News | Stem Cell Therapies| November 13, 2015
A new study appearing in STEM CELLS Translational Medicine (SCTM) describes a highly efficient, protein-based method...
angina, abnormal heart blood flow, female-pattern heart disease, Cedars-Sinai Heart Institute study, AHA Scientific Sessions
News | Cardiac Diagnostics| November 13, 2015
Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, a new Cedars-Sinai Heart Institute...
News | Antiplatelet and Anticoagulation Therapies| November 12, 2015
Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung...
pharmacist-physician collaboration, high blood pressure control, minority and low-income populations
News | Hypertension| November 12, 2015
November 12, 2015 — A pharmacist-physician collaborative effort to control blood pressure among a diverse group of pa
obese kids, eight years old, heart disease, MRI, Linyuan Jing
News | Cardiac Diagnostics| November 11, 2015
Imaging tests of obese children — some as young as 8 years old — showed signs of significant heart disease and heart...
Overlay Init